Europe Platelet Rich Plasma Market, Product Type (Pure-PRP, Leukocyte-Rich PRP, Pure Platelet Rich Fibrin, Others)

Europe Platelet Rich Plasma Market, Product Type (Pure-PRP, Leukocyte-Rich PRP, Pure Platelet Rich Fibrin, Others), By Origin (Autologous, Allogeneic/Homologues), By Application (Orthopaedics, Cosmetic Surgery and Dermatology, Neurosurgery, Cardiothoracic Surgery, General Surgery, Urology, Others), and By Country (U.K., Germany, France, Italy, Spain, Russia, Rest of Europe)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


Platelet-rich plasma consists of two elements: plasma, or the liquid portion of blood, and platelets, a type of blood cell that plays an important role in healing throughout the body. Platelets are well-known for their clotting abilities, but they also contain growth factors that can trigger cell reproduction and stimulate tissue regeneration or healing in the treated area. Platelet-rich plasma is simply blood that contains more platelets than normal. Autologous platelet-rich plasma (PRP) is a blood plasma concentrate enriched with platelet count above the baseline of whole blood prepared from patient’s own blood. PRP is injected directly at the site of inflamed tissue releasing growth factor which stimulates and increases number of reparative cell in patient body. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. PRP is used for treatment of injured tendons, ligaments, muscles and joints Increasing prevalence of musculoskeletal injuries along with increasing prevalence of knee osteoarthritis is expected to boost growth of Europe platelet-rich plasma market over the forecast period.

Market Dynamics

Increasing adoption of organic growth strategies, such as product launch by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, on February 14 2023, Royal Biologics, an orthobiologics & life science company, announced the commercial launch of BIOINCYTE PRFM, a next-generation Platelet Rich Plasma (PRP) system, which converts traditional PRP to Platelet Rich Fibrin Matrix (PRFM) formulations and eliminates extensive contamination of red blood cells & white blood cells during the formulation of PRP.

Key features of the study:

This report provides in-depth analysis of the Europe platelet rich plasma, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the europe platelet rich plasma based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study are Vivostat A/S, Estar Medical, CosmoFrance Inc., Kelly Harris Aesthetics, Arthrex, Inc., Terumo Corporation, T-Biotechnology Ltd. St., EmCyte Corporation, Johnson & Johnson Private Limited, Zimmer Biomet, PRP Concepts, ADVACARE PHARMA, Isto Biologics, Arthrex, Inc., Stryker, GLOFINN, Medira Ltd, Regen Lab SA, Estar Technologies Ltd.

Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global platelet rich plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe platelet rich plasma

Detailed Segmentation:

Europe Platelet Rich Plasma Market, By PRP Type:

Pure-PRP

Leukocyte-Rich PRP

Pure Platelet Rich Fibrin

Others

Europe Platelet Rich Plasma Market, By Origin:

Autologous

Allogeneic/Homologues

Europe Platelet Rich Plasma Market, By Application:

Orthopaedics

Cosmetic Surgery and Dermatology

Neurosurgery

Cardiothoracic Surgery

General Surgery

Urology

Others

Europe Infection Surveillance Market, By Country:

U.K.

Germany

France

Italy

Spain

Russia

Rest of Middle East

Company Profiles

Vivostat A/S*

Company Highlights

Products Portfolio

Key Highlights

Financial Performance

Strategies

Estar Medical

CosmoFrance Inc.

Kelly Harris Aesthetics

Arthrex, Inc.

Terumo Corporation

T-Biotechnology Ltd. St.

EmCyte Corporation

Johnson & Johnson Private Limited

Zimmer Biomet

PRP Concepts

ADVACARE PHARMA

Isto Biologics

Arthrex, Inc.

Stryker

GLOFINN

Medira Ltd

Regen Lab SA

Estar Technologies Ltd.

“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By PRP Type
Market Snapshot, By Origin
Market Snapshot, By Application
Market Snapshot, By Country
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Attractiveness Analysis
Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
PORTER’s Analysis
Pricing Analysis (2021)
4. Europe Platelet rich Plasma Market– COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Europe Platelet rich Plasma Market, By PRP Type, 2018 – 2030, (US$ Million)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends
Pure-PRP
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
Leukocyte-Rich PRP
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
Pure Platelet Rich Fibrin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
6. Europe Platelet rich Plasma Market, By Origin, 2018 – 2030, (US$ Million)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends
Autologous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
Allogeneic/Homologues
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
7. Europe Platelet rich Plasma Market, By Application, 2018 – 2030, (US$ Million)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends
Orthopaedics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
Cosmetic Surgery and Dermatology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
Neurosurgery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
Cardiothoracic Surgery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
General Surgery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
Urology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
8. Europe Platelet rich Plasma Market, By Country, 2018 – 2030, (US$ Million)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Regions, 2018–2030
Regional Trends
U.K.
Introduction
Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
Germany
Introduction
Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
France
Introduction
Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
Italy
Introduction
Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
Spain
Introduction
Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
Russia
Introduction
Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
Rest of Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
9. Competitive Landscape
Vivostat A/S
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Estar Medical
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
CosmoFrance Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Kelly Harris Aesthetics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Arthrex, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Terumo Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
T-Biotechnology Ltd. St.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
EmCyte Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Johnson & Johnson Private Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Zimmer Biomet
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
PRP Concepts
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
ADVACARE PHARMA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Isto Biologics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Arthrex, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Stryker
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
GLOFINN
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Medira Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Regen Lab SA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Estar Technologies Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
10. Section
Research Methodology
About Us
*Browse 16 market data tables and 10 figures on “Europe Platelet Rich Plasma Market”- Europe forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings